Pamine Forte Side Effects
Generic name: methscopolamine
Medically reviewed by Drugs.com. Last updated on Oct 25, 2023.
Note: This document contains side effect information about methscopolamine. Some dosage forms listed on this page may not apply to the brand name Pamine Forte.
Applies to methscopolamine: oral tablets.
Side effects include:
Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).
For Healthcare Professionals
Applies to methscopolamine: oral tablet.
Cardiovascular
Frequency not reported: Tachycardia, palpitation[Ref]
Hypersensitivity
Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis[Ref]
Nervous system
Frequency not reported: Headaches, drowsiness, dizziness, loss of taste[Ref]
Ocular
Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension[Ref]
Gastrointestinal
Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia[Ref]
Dermatologic
Frequency not reported: Decreased sweating, urticaria and other dermal manifestations[Ref]
Genitourinary
Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation[Ref]
Other
Frequency not reported: Weakness[Ref]
Psychiatric
Frequency not reported: Nervousness, mental confusion, insomnia[Ref]
More about Pamine Forte (methscopolamine)
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
- Breastfeeding
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
References
1. Product Information. Pamine Forte (methscopolamine). PharmaDerm. 2006.
2. Product Information. Methscopolamine Bromide (methscopolamine). Boca Pharmacal Inc. 2017.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.